Literature DB >> 7774575

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

B Chini1, B Mouillac, Y Ala, M N Balestre, S Trumpp-Kallmeyer, J Hoflack, J Elands, M Hibert, M Manning, S Jard.   

Abstract

Using a three-dimensional model of G protein-coupled receptors (GPCR), we have previously succeeded in docking the neurohypophysial hormone arginine-vasopressin (AVP) into the V1a receptor. According to this model, the hormone is completely embedded in the transmembrane part of the receptor. Only the side chain of the Arg residue at position 8 projects outside the transmembrane core of the receptor and possibly interacts with a Tyr residue located in the first extracellular loop at position 115. Residue 8 varies in the two natural neurohypophysial hormones, AVP and oxytocin (OT); similarly, different residues are present at position 115 in the different members of the AVP/OT receptor family. Here we show that Arg8 is crucial for high affinity binding of AVP to the rat V1a receptor. Moreover, when Tyr115 is replaced by an Asp and a Phe, the amino acids naturally occurring in the V2 and in the OT receptor subtypes, the agonist selectivity of the V1a receptor switches accordingly. Our results indicate that the interaction between peptide residue 8 and the receptor residue at position 115 is not only crucial for agonist high affinity binding but also for receptor selectivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774575      PMCID: PMC398323          DOI: 10.1002/j.1460-2075.1995.tb07211.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.

Authors:  S Trumpp-Kallmeyer; J Hoflack; A Bruinvels; M Hibert
Journal:  J Med Chem       Date:  1992-09-18       Impact factor: 7.446

Review 2.  Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function.

Authors:  J Ostrowski; M A Kjelsberg; M G Caron; R J Lefkowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  1992       Impact factor: 13.820

3.  Homology between neurohypophyseal hormone receptors.

Authors:  M Wheatley; J Howl; A Morel; A R Davies
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

4.  Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor.

Authors:  E Kojro; P Eich; G Gimpl; F Fahrenholz
Journal:  Biochemistry       Date:  1993-12-14       Impact factor: 3.162

Review 5.  Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin.

Authors:  M Manning; W H Sawyer
Journal:  J Recept Res       Date:  1993

Review 6.  Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution.

Authors:  R Acher
Journal:  Regul Pept       Date:  1993-04-29

7.  Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.

Authors:  M Thibonnier; C Auzan; Z Madhun; P Wilkins; L Berti-Mattera; E Clauser
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

8.  Structure, function, and phylogeny of [Arg8]vasotocin receptors from teleost fish and toad.

Authors:  S Mahlmann; W Meyerhof; H Hausmann; J Heierhorst; C Schönrock; H Zwiers; K Lederis; D Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Projection structure of rhodopsin.

Authors:  G F Schertler; C Villa; R Henderson
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

10.  Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.

Authors:  V Gorbulev; H Büchner; A Akhundova; F Fahrenholz
Journal:  Eur J Biochem       Date:  1993-07-01
View more
  35 in total

1.  Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.

Authors:  S Nakamura; Y Yamamura; S Itoh; T Hirano; K Tsujimae; M Aoyama; K Kondo; H Ogawa; T Shinohara; K Kan; Y Tanada; S Teramoto; T Sumida; S Nakayama; K Sekiguchi; T Kambe; G Tsujimoto; T Mori; M Tominaga
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.

Authors:  A Giełdoń; R Kaźmierkiewicz; R Slusarz; J Ciarkowski
Journal:  J Comput Aided Mol Des       Date:  2001-12       Impact factor: 3.686

3.  Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.

Authors:  Daniela Braida; Andrea Donzelli; Roberta Martucci; Valeria Capurro; Marta Busnelli; Bice Chini; Mariaelvina Sala
Journal:  Psychopharmacology (Berl)       Date:  2011-09-29       Impact factor: 4.530

4.  Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor.

Authors:  H Hausmann; A Richters; H J Kreienkamp; W Meyerhof; H Mattes; K Lederis; H Zwiers; D Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

5.  Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.

Authors:  Marta Busnelli; Aude Saulière; Maurice Manning; Michel Bouvier; Celine Galés; Bice Chini
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

6.  The 3D structure of the binding pocket of the human oxytocin receptor for benzoxazine antagonists, determined by molecular docking, scoring functions and 3D-QSAR methods.

Authors:  Balázs Jójárt; Tamás A Martinek; Arpád Márki
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

7.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

8.  Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors.

Authors:  J Howl; M Wheatley
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 9.  Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.

Authors:  J Peter; H Burbach; R A Adan; S J Lolait; F W van Leeuwen; E Mezey; M Palkovits; C Barberis
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

10.  Evolutionary pattern in the OXT-OXTR system in primates: coevolution and positive selection footprints.

Authors:  Pedro Vargas-Pinilla; Vanessa Rodrigues Paixão-Côrtes; Pamela Paré; Luciana Tovo-Rodrigues; Carlos Meton de Alencar Gadelha Vieira; Agatha Xavier; David Comas; Alcides Pissinatti; Marialva Sinigaglia; Maurício Menegatti Rigo; Gustavo Fioravanti Vieira; Aldo B Lucion; Francisco Mauro Salzano; Maria Cátira Bortolini
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.